Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention
制定综合性、基于恢复的急性后 COVID-19 综合症 (PACS) 心理治疗干预措施
基本信息
- 批准号:10586328
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-10-01 至 2024-09-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAddressAmericanAnxietyAnxiety DisordersArthralgiaCOVID-19COVID-19 patientCardiovascular systemCaringChronicClimactericClinicalConsultationsContractsCoping SkillsCoupledDataDevelopmentDiseaseDistressEducationEmploymentEpidemiologyFatigueFeedbackFosteringFutureGoalsHeadacheHealthHigh PrevalenceImpairmentIndividualInfectionInterventionInterviewKnowledgeLeadershipLifeLife StyleLonelinessLong COVIDLongitudinal StudiesMeasuresMedicalMemory impairmentMental DepressionMental HealthMental disordersModelingNeeds AssessmentNeurologicNeurologic SymptomsNutritionistPainPain DisorderParticipantPatientsPersonsPhasePopulationPost-Traumatic Stress DisordersPrevalenceProcessProtocols documentationProviderPsychological adjustmentPsychotherapyQuality of lifeRecoveryRegistriesRehabilitation therapySamplingServicesSleep DisordersSleeplessnessSpecialistSymptomsTechniquesTestingTimeUnited StatesUnited States Department of Veterans AffairsUnited States National Institutes of HealthVeteransacceptability and feasibilityarmbasecohortcommon symptomcopingcoronavirus diseasedesigndisorder later incidence preventionempowermentexperiencefitnessflexibilityfollow-upfunctional disabilityfunctional improvementfunctional statusgroup interventionhealth assessmentimprovedinnovationinterdisciplinary approachmedical schoolsneurological rehabilitationnoveloptimismphysical conditioningpost SARS-CoV-2 infectionprogramspsychosocialpulmonary symptomrehabilitation strategyresiliencesatisfactionskillsskills trainingsleep healthsymptomatologytelehealththerapy development
项目摘要
Project Abstract
At present, 34.6 million people in the United States, and 273,232 Veterans tested or treated in Veteran Affairs
facilities contracted COVID-19. While the exact prevalence of Post-Acute COVID-19 Syndrome (PACS) among
Veterans is unknown, estimates of psychiatric/neurological PACS using a large global sample of COVID-19
patients (N=236,379) suggest a prevalence of approximately 11,390,400 Americans, and 90,311 Veterans in
VA care, with rates likely to increase over time. Moreover, large scale studies suggest up to 35% of individuals
experience functional impairment 8 months after COVID-19, and high prevalence of post-infection mental illness
including anxiety disorders, depression, and post-traumatic stress disorder. Using longitudinal data from our
academic affiliate, Icahn School of Medicine at Mount Sinai’s COVID registry (n≈1200), and local James J. Peters
VA’s Clinical PACS program, coupled with our expertise in recovery-based psychotherapy, we are uniquely
poised to develop an innovative treatment for Veterans struggling with PACS.
Our intervention aims to improve psychological adjustment to PACS symptoms, promote resiliency, and facilitate
coping, all of which can impact functional status and quality of life. The PACS-Coping and Recovery (PACS-CR)
intervention we aim to develop focuses on psychological adjustment and coping, and augments medical,
rehabilitative and neurological treatment for this population. Our approach is based on the CHIME model of
personal recovery which includes five overarching processes: 1) Connectedness; 2) Hope and optimism about
the future; 3) Identity; 4) Meaning in life; and 5) Empowerment. We will target the CHIME processes using
established psychotherapeutic techniques such as skills training, acceptance-based and identity-based
principles.
Based on adaptations from existing recovery-based and COVID-19 distress group interventions that our team
has developed and piloted, we are proposing a treatment framework that consists of a core of twelve 90-minutes
sessions (1x/week x 12 weeks) with additional weekly sessions on specialized topics that are optional. We are
proposing a treatment development NIH Stage 1A study to develop a Post-Acute COVID-19 Syndrome
psychotherapeutic intervention, “PACS Coping and Recovery” (PACS-CR) through an iterative development
process while collecting pilot data to assess its acceptability and feasibility.
Our treatment development SPiRE will focus on 1) determining the treatment needs of Veterans with PACS, 2)
developing the treatment using pilot qualitative data and aided by stakeholder feedback, 3) refining the
intervention by three iterative pilots of our groups, testing both in person and telehealth versions. Pre and post
measures will be utilized to track functional improvement and the degree to which this recovery-focused
intervention has enabled the veterans to engage in meaningful life changes.
项目摘要
目前,美国有3460万人、273,232名退伍军人在退伍军人事务部接受了检测或治疗
设施感染了 COVID-19,而急性后 COVID-19 综合症 (PACS) 的确切患病率。
退伍军人未知,使用全球大量 COVID-19 样本对精神病学/神经学 PACS 进行估计
患者 (N=236,379) 表明,大约有 11,390,400 名美国人和 90,311 名退伍军人患病
此外,大规模研究表明,VA 护理率可能会随着时间的推移而增加,高达 35%。
COVID-19 后 8 个月出现功能障碍,感染后精神疾病患病率很高
使用我们的纵向数据,包括焦虑症、抑郁症和创伤后应激障碍。
学术附属机构、西奈山伊坎医学院的新冠病毒登记处 (n≈1200) 和当地 James J. Peters
VA 的临床 PACS 计划,加上我们在基于康复的心理治疗方面的专业知识,使我们具有独特的优势
准备为患有 PACS 的退伍军人开发一种创新疗法。
我们的干预措施旨在改善对 PACS 症状的心理适应、增强弹性并促进
应对,所有这些都会影响功能状态和生活质量(PACS-CR)。
我们旨在开发的干预措施侧重于心理调整和应对,并增强医疗、
我们针对这一人群的康复和神经治疗方法基于 CHIME 模型。
个人康复包括五个总体过程:1)联系;2)希望和乐观;
未来;3) 身份;4) 生命的意义;以及 5) 我们将利用 CHIME 流程来实现目标。
已建立的心理治疗技术,例如技能培训、基于接受和基于身份的心理治疗技术
原则。
根据我们团队对现有基于恢复和 COVID-19 困扰群体干预措施的改编
已经开发并试点,我们提出了一个治疗框架,其中包括十二个 90 分钟的核心
课程(1 次/周 x 12 周)以及可选的每周额外课程。
提议进行治疗开发 NIH 1A 阶段研究以开发急性后 COVID-19 综合症
通过迭代开发的心理治疗干预“PACS 应对和恢复”(PACS-CR)
过程,同时收集试点数据以评估其可接受性和可行性。
我们的治疗开发 SPiRE 将重点关注 1) 通过 PACS 确定退伍军人的治疗需求,2)
使用试点定性数据并在利益相关者反馈的帮助下开发治疗方法,3)完善
我们小组的三名迭代试点进行干预,在现场和远程医疗版本之前和之后进行测试。
将利用措施来跟踪功能改进以及这种以恢复为重点的程度
干预使退伍军人能够进行有意义的生活改变。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marianne Goodman其他文献
Marianne Goodman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marianne Goodman', 18)}}的其他基金
Center for Harmonizing and Improving Interventions to Prevent Suicide (CHIIPS)
协调和改进预防自杀干预措施中心 (CHIIPS)
- 批准号:
10662785 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Center for Harmonizing and Improving Interventions to Prevent Suicide (CHIIPS)
协调和改进预防自杀干预措施中心 (CHIIPS)
- 批准号:
10662785 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention
制定综合性、基于恢复的急性后 COVID-19 综合症 (PACS) 心理治疗干预措施
- 批准号:
10683267 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention
制定综合性、基于恢复的急性后 COVID-19 综合症 (PACS) 心理治疗干预措施
- 批准号:
10683267 - 财政年份:2022
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
9889256 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
10662374 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk for suicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
10558287 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
10662374 - 财政年份:2020
- 资助金额:
-- - 项目类别:
CTBI: Traumatic brain injury-induced inflammation effects on cognitive evaluations and response inhibition: Mechanisms of increased risk forsuicidality
CTBI:创伤性脑损伤诱发的炎症对认知评估和反应抑制的影响:自杀风险增加的机制
- 批准号:
10425246 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Group (“Project Life Force”) vs. Individual Suicide Safety Planning RCT
团体(“生命力计划”)与个人自杀安全计划随机对照试验
- 批准号:
10038807 - 财政年份:2018
- 资助金额:
-- - 项目类别:
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Next Generation Opto-GPCRs for Neuromodulatory Control
用于神经调节控制的下一代 Opto-GPCR
- 批准号:
10515612 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Development and Validation of the Down Syndrome Regression Rating Scales
唐氏综合症回归评定量表的开发和验证
- 批准号:
10781052 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Racial Differences in Hospital-Associated Disability and Acute and Post-Acute Care Physical Therapy Utilization
医院相关残疾以及急性和急性后护理物理治疗利用的种族差异
- 批准号:
10785500 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The Protective and Pathologic Features of the EVD Survivor Immune System
埃博拉病毒病幸存者免疫系统的保护和病理特征
- 批准号:
10639583 - 财政年份:2023
- 资助金额:
-- - 项目类别: